We are live on
!
Find out more
MCM
McRae Capital Management Portfolio holdings
AUM
$508M
1-Year Est. Return
14.21%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+14.21%
3 Year Est. Return
+59.23%
5 Year Est. Return
+71.2%
10 Year Est. Return
+359.88%
AUM
$216M
AUM Growth
-$7.9M
(-3.5%)
Cap. Flow
-$8.39M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
41.54%
Holding
102
New
6
Increased
52
Reduced
19
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$6.38M |
| 2 |
Medtronic
MDT
|
+$743K |
| 3 |
Pentair
PNR
|
+$649K |
| 4 |
AbbVie
ABBV
|
+$319K |
| 5 |
IBM
IBM
|
+$302K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$9.75M |
| 2 |
Baxter International
BAX
|
+$4.48M |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$4.35M |
| 4 |
Lowe's Companies
LOW
|
+$371K |
| 5 |
Omnicom Group
OMC
|
+$324K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.19% |
| 2 | Technology | 15.51% |
| 3 | Financials | 15.01% |
| 4 | Industrials | 10.76% |
| 5 | Consumer Discretionary | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $11.8M | 5.46% |
119,630
+2,525
| +2% | +$261K |
|
2
PepsiCo
PEP
$193B
| $9.91M | 4.58% |
93,549
-2,700
| -3% | -$279K |
|
|
3
Medtronic
MDT
$117B
| $9.32M | 4.31% |
107,379
+9,185
| +9% | +$743K |
|
|
4
Lowe's Companies
LOW
$117B
| $8.84M | 4.09% |
111,696
-4,800
| -4% | -$371K |
|
5
Microsoft
MSFT
$3.81T
| $8.73M | 4.04% |
170,589
+1,918
| +1% | +$99.7K |
|
|
6
Omnicom Group
OMC
$24.2B
| $8.6M | 3.98% |
105,505
-3,900
| -4% | -$324K |
|
7
Wells Fargo
WFC
$262B
| $8.37M | 3.87% |
176,834
+3,000
| +2% | +$146K |
|
8
AT&T
T
$178B
| $8.24M | 3.81% |
252,565
-1,149
| -0.5% | -$34.2K |
|
9
US Bancorp
USB
$97.3B
| $8.2M | 3.79% |
203,270
-750
| -0.4% | -$31.2K |
|
10
Eaton
ETN
$156B
| $7.82M | 3.62% |
130,903
-2,600
| -2% | -$160K |
|
11
GE Aerospace
GE
$355B
| $7.74M | 3.58% |
51,315
-905
| -2% | -$132K |
|
12
Target
TGT
$74.1B
| $7.65M | 3.54% |
109,570
+950
| +0.9% | +$70.9K |
|
13
Accenture
ACN
$116B
| $7.43M | 3.44% |
65,590
-1,925
| -3% | -$223K |
|
|
14
IBM
IBM
$222B
| $7M | 3.24% |
48,248
+2,107
| +5% | +$302K |
|
|
15
Labcorp
LH
$27.2B
| $6.63M | 3.07% |
+59,253
| New | +$6.38M |
|
|
DNKN
16
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $6.48M | 3% |
148,645
+4,500
| +3% | +$206K |
|
17
PayPal
PYPL
$45.9B
| $6.36M | 2.94% |
174,155
+600
| +0.3% | +$22.9K |
|
|
DNB
18
DELISTED
Dun & Bradstreet
DNB
| $5.6M | 2.59% |
45,935
-1,150
| -2% | -$135K |
|
|
NUAN
19
DELISTED
Nuance Communications, Inc.
NUAN
| $5.36M | 2.48% |
396,107
+12,705
| +3% | +$189K |
|
|
TUP
20
DELISTED
Tupperware Brands Corporation
TUP
| $5.01M | 2.32% |
89,105
+2,425
| +3% | +$138K |
|
21
ConocoPhillips
COP
$157B
| $4.38M | 2.02% |
100,413
-25
| -0% | -$1.1K |
|
22
Johnson & Johnson
JNJ
$646B
| $3.75M | 1.73% |
30,886
+1,073
| +4% | +$122K |
|
23
Kinder Morgan
KMI
$70.3B
| $3.74M | 1.73% |
199,592
+2,703
| +1% | +$48.2K |
|
24
Quanta Services
PWR
$90.6B
| $3.48M | 1.61% |
150,650
+8,050
| +6% | +$186K |
|
25
ExxonMobil
XOM
$644B
| $3.41M | 1.58% |
36,335
+1,591
| +5% | +$141K |
|
Similar funds
5NPW
BFA
HC
RIG
FSA
IIC
REMPR
OPA
McRae Capital Management's Q2 2016 Portfolio in Review
As of Q2 2016, McRae Capital Management held 102 positions worth $216M, down 3.5% from $224M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
McRae Capital Management withdrew a net $8.39M in Q2 2016, closing 3 positions and reducing 19 holdings. Its most notable exit was Travelers Companies, an estimated $9.75M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, McRae Capital Management opened a new position in Labcorp worth $6.63M.
- McRae Capital Management's largest Q2 2016 buy was Labcorp: 59,253 shares worth $6.63M.
- McRae Capital Management added most to Medtronic in Q2 2016, an estimated $743K increase.
- McRae Capital Management's biggest Q2 2016 reduction was Lowe's Companies, cutting an estimated $371K.
- McRae Capital Management fully exited Travelers Companies in Q2 2016, selling an estimated $9.75M.
- McRae Capital Management's ten largest holdings make up 42% of its $216M portfolio in Q2 2016.
- McRae Capital Management opened 6 new positions and closed 3 in Q2 2016.
- McRae Capital Management's portfolio value fell 3.5% quarter-over-quarter to $216M.
Based on McRae Capital Management's 13F filing for Q2 2016, filed 2 Aug 2016.